AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]

The US FDA has approved Revolution Medicines’ daraxonrasib for adults [...]

Biogen’s felzartamab has been approved in China as a treatment [...]

Agenus has reported deep tumour responses and no observed colorectal [...]

CEPI will provide up to $16.5 million to Minapharm to [...]

Sagimet Biosciences is preparing to begin screening patients for its [...]

The FDA has approved ViiV Healthcare’s Tivicay PD for children [...]

START and Allegheny Health Network are establishing a new early-phase [...]

Polaryx Therapeutics is preparing to start its Phase 2 SOTERIA [...]

Lumen Bioscience has received up to $7m in US government [...]